SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 688505 for the last quarter is 141.28 M CNY, and it's 23.01% lower compared to the previous quarter. The net income of Q4 23 is 18.74 M CNY.